1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Dolasetron mesylate injection
Trade Name:
Anzemet
Manufacturer/Distributor:
Sanofi-Aventis Canada
1-800-267-7927 www.sanofi-aventis.ca
Classification:
Antiemetic
ATC Class:
A04AA04 - Dolasetron
Status:
discontinued
Notice of Compliance (yyyy/mm/dd):
2011/04/26
Date Marketed in Canada (yyyy/mm/dd):
2011/05/10
Presentation:
Inection: 20 mg/mL. DIN: 02231380
Comments:
The injectable form of dolasetron is being withdrawn from the Canadian market due to the potential risk of developing arrhythmias (prolongation of QTc interval) at doses used for prevention of nausea and vomiting in adults undergoing chemotherapy. The tablets will still be available as the risk of developing an abnormal heart rhythm is less than seen with the injectable from.
Back to:
Drug Product Listings 
